This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor.
1-(BENZO[D][1,3]DIOXOL-5-YL)-N-(PHENYL)CYCLOPROPANE-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS FOR THE TREATMENT OF CYSTIC FIBROSIS
申请人:VERTEX PHARMACEUTICALS INCORPORATED
公开号:EP2016065A2
公开(公告)日:2009-01-21
US7511066B2
申请人:——
公开号:US7511066B2
公开(公告)日:2009-03-31
[EN] MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS<br/>[FR] MODULATEURS DE TRANSPORTEURS DE CASSETTE LIANT L'ATP
申请人:VERTEX PHARMA
公开号:WO2007087066A2
公开(公告)日:2007-08-02
[EN] Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP -Binding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR"). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention. [FR] La présente invention concerne des composés et des compositions pharmaceutiquement acceptables en provenant, utilisés comme modulateurs des transporteurs de cassette liant l'ATP (ABC) ou fragments en provenant, parmi lesquels le régulateur de la Conductance transmembranaire de la fibrose kystique (CFTR). Cette invention traite aussi de procédés de traitement de maladies facilitées par le transporteur ABC utilisant les composés de la présente invention.